What is Opus Genetics's other comprehensive income (loss)?

Opus Genetics (IRD) reported other comprehensive income (loss) of $0 in Q1 2026.

What does other comprehensive income (loss) mean?

Captures changes in equity resulting from non-owner sources that are excluded from net income, such as unrealized gains or losses on certain investments or foreign currency translation adjustments. It provides a broader view of a company's financial health beyond standard operating performance.

Opus Genetics IRD Other comprehensive income (loss)

Other comprehensive income (loss) at other companies

RegenxbioRGNX

-$183K-771%

Other financials

Income statement

See full

Revenue$2.2M-50.6%

Operating income-$14.4M-44.7%

Net income-$65.5M-700%

EPS (diluted)-$0.75-213%

Balance sheet

See full

Cash & equivalents$60.0M+43.5%

Total debt$1.2M—

Total equity-$45.8M-1,004%

Total assets$66.8M+38.7%

Cash flow

See full

Operating cash flow-$12.7M-41.5%

Valuation

See full

Market cap$307.14M+442%

Enterprise value$248.38M—

P/S25.6×+21.5×

Profitability

See full

Operating margin-359.1%-68.9pp

Net margin-892.4%-12,322pp

Returns & leverage

See full

Return on equity-449.4%-2,573pp

Debt / equity0.1×—

Current ratio7.1×+5.2×

Where this comes from

Reported directly by Opus Genetics in its filing.

Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossNetOfTax.

The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's other comprehensive income (loss).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Opus Genetics's other comprehensive income (loss)?: Opus Genetics (IRD) reported other comprehensive income (loss) of $0 in Q1 2026.
What does other comprehensive income (loss) mean?: Captures changes in equity resulting from non-owner sources that are excluded from net income, such as unrealized gains or losses on certain investments or foreign currency translation adjustments. It provides a broader view of a company's financial health beyond standard operating performance.